Aclaris Therapeutics, Inc (ACRS) insider trading
Every open-market stock purchase and sale by Aclaris Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1.4M over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Anand Mehra (Insider), $1.5M, 22 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.4M (1 sale). Last close $6.09 on Aug 6, 2026.
Recent ACRS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 1, 2026 | Roland Wilhelm Kolbeck (C-suite exec) | Sold (not open market) | $64.4K |
| Aug 1, 2026 | Roland Wilhelm Kolbeck (C-suite exec) | Bought (not open market) | — |
| Jun 5, 2026 | Maxine Gowen (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Andrew N Schiff (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Christopher P. Molineaux (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Vincent Milano (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | Anand Mehra (Insider) | Bought (not open market) | — |
| Jun 5, 2026 | William D. Humphries (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Vincent Milano (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Anand Mehra (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Maxine Gowen (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Anand Mehra (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Christopher P. Molineaux (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Christopher P. Molineaux (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | William D. Humphries (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | William D. Humphries (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Maxine Gowen (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Vincent Milano (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Andrew N Schiff (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Andrew N Schiff (Insider) | Bought (not open market) | — |
| May 1, 2026 | Jesse Wayne Hall (C-suite exec) | Sold (not open market) | $41.1K |
| May 1, 2026 | Jesse Wayne Hall (C-suite exec) | Bought (not open market) | — |
| Apr 23, 2026 | Braden Michael Leonard (Insider) | Sold | $1.4M |
| Mar 1, 2026 | Kevin Balthaser (CFO) | Sold (not open market) | $1.9K |
| Mar 1, 2026 | Kevin Balthaser (CFO) | Bought (not open market) | — |
Who's trading ACRS
- Roland Wilhelm Kolbeck, C-suite exec: other filings, last Aug 1, 2026
- Andrew N Schiff, Insider: other filings, last Jun 5, 2026
- Maxine Gowen, Insider: other filings, last Jun 5, 2026
- William D. Humphries, Insider: other filings, last Jun 5, 2026
- Vincent Milano, Insider: other filings, last Jun 5, 2026
- Christopher P. Molineaux, Insider: other filings, last Jun 5, 2026
- Anand Mehra, Insider: other filings, last Jun 5, 2026
- Jesse Wayne Hall, C-suite exec: other filings, last May 1, 2026
- Braden Michael Leonard, Insider: sold $1.4M (1 sale), last Apr 23, 2026
- Kevin Balthaser, CFO: other filings, last Mar 1, 2026
- James Loerop, C-suite exec: other filings, last Feb 3, 2026
- Hugh M. Davis, COO: other filings, last Feb 3, 2026
- Neal Walker, CEO: other filings, last Feb 3, 2026
Get free alerts when an insider at Aclaris Therapeutics, Inc files a new trade →